The first of the World Health Organization WHO Blue Book 6th edition series from IARC - International Agency for Research on Cancer / World Health Organization is out in print !!
The latest evidence-based updates on tumor classifications.
Whole Slide Images (WSIs) are included for almost all entities!
@ESP_Pathology@TheUSCAP@AACR@ASCO@Pathologists@IARCWHO
I will be giving talks at UC San Diego (Dept Bioengineering) and Sanford Burnham Prebys Institute this coming Friday and the following Tuesday in La Jolla.
I will talk about 3D mapping of solid tumors and new CAR T therapies to resolve them.
Hope to see you there.
The International Journal of Gynecological Pathology November online edition is now live!
✨Browse the latest research here: https://t.co/M3ZwDWamBX
📷Non-Members: Keep an eye out for open access articles — we’ll share them as they become available!
@ISGynP@BAGPGynPath
Exploring Breakthroughs in Immunotherapy for Autoimmune Diseases
The Congress on Cellular and Humoral Immunotherapy in Autoimmunity (CHIA 2025) brings together experts to discuss cutting-edge advancements in cellular and humoral immunotherapies. This year’s focus highlights the intersection of treatments for hematologic malignancies and autoimmune diseases, covering topics like CAR T-cell therapy, T-cell engagers, and personalized treatment approaches.
📅 Date: September 18-20, 2025
📍 Location: The Star Meridian, Paris, France + Virtual
🎓 Earn CME credits
🔗 Learn more: https://t.co/JclfaaXJvc
Engage with leading researchers, explore innovative therapies, and deepen your expertise in autoimmunity treatment.
#Immunotherapy #FranceMedicalconference #AutoimmuneDiseases #CAR-T #CHIA2025 #Rheumatology #Hematology #eMedEvents
You may not see it again on a PAP test - A young teen with uterine cervical lesion, "Clear Cell Carcinoma". Cyto was called "Adenocarcinoma, NOS". (SurePath)
Without the intranuclear inclusions, these "oncocytoid" cells would have been a bit difficult to be called "Papillary Thyroid Carcinoma" on FNA. Follow-up, "PTC, Tall Cell Subtype".
Today I had the opportunity to serve as a reviewer for the “Young Investigator Day” poster session at Johns Hopkins Pathology, evaluating and scoring some outstanding research presentations.
Aspirin a gift that keeps giving!
Novel immunosuppressive pathway that limits T cell immunity to cancer metastasis provides mechanistic insights into the anti-metastatic activity of aspirin and paves the way for more effective anti-metastatic immunotherapies! @Nature (2025). https://t.co/8v38UdarYE
Inspired by this fascinating AI poster at#USCAP2025 and a conversation full of practical tips and insights with Dr. Bryan Dangott. I learned so much and can’t wait to apply it to my own project. Excited for future collaborations between @MayoClinicPath and @JHUPath